Two Sigma Advisers
HOOK

Two Sigma Advisers’s HOOKIPA Pharma HOOK Stock Holding History

Two Sigma Advisers’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,690
Closed -$27.8K – 2381
2024
Q2 		$27.8K Buy
4,690
+1,130
+32% +$8.96K ﹤0.01% 2390
2024
Q1 		$25.3K Buy
+3,560
New +$25.3K ﹤0.01% 2390
2023
Q3 		– Sell
-1,770
Closed -$15.6K – 2472
2023
Q2 		$15.6K Buy
+1,770
New +$19.7K ﹤0.01% 2333
2022
Q1 		– Sell
-25,360
Closed -$591K – 2801
2021
Q4 		$591K Buy
25,360
+16,800
+196% +$675K ﹤0.01% 1840
2021
Q3 		$504K Buy
8,560
+7,390
+632% +$536K ﹤0.01% 1919
2021
Q2 		$107K Sell
1,170
-1,160
-50% -$155K ﹤0.01% 2341
2021
Q1 		$313K Buy
+2,330
New +$281K ﹤0.01% 2207

Other funds holding HOOK

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Advisers's HOOK Position: Q3 2024 in Review

Two Sigma Advisers sold out of HOOKIPA Pharma (HOOK) in Q3 2024, closing a stake of 4,690 shares — an estimated $27.8K sold.

Two Sigma Advisers first reported a position in HOOK in Q1 2021 and held it in 7 quarters. The position peaked at $591K in Q4 2021. 35 funds tracked by Wall St. Rank hold HOOK as of Q3 2024.

  • Two Sigma Advisers reported no remaining HOOKIPA Pharma position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 4,690 HOOKIPA Pharma shares in Q3 2024, an estimated $27.8K.
  • Two Sigma Advisers first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 7 quarters.
  • Two Sigma Advisers's HOOKIPA Pharma position peaked at $591K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.